Cerebral hemorrhage after passive anti-Abeta immunotherapy - PubMed (original) (raw)
. 2002 Nov 15;298(5597):1379.
doi: 10.1126/science.1078259.
Affiliations
- PMID: 12434053
- DOI: 10.1126/science.1078259
Cerebral hemorrhage after passive anti-Abeta immunotherapy
M Pfeifer et al. Science. 2002.
No abstract available
Comment in
- Cerebral hemorrhage and amyloid-beta.
Atwood CS, Perry G, Smith MA. Atwood CS, et al. Science. 2003 Feb 14;299(5609):1014; author reply 1014. doi: 10.1126/science.299.5609.1014b. Science. 2003. PMID: 12586924 No abstract available.
Similar articles
- Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA. Boche D, et al. Brain. 2008 Dec;131(Pt 12):3299-310. doi: 10.1093/brain/awn261. Epub 2008 Oct 25. Brain. 2008. PMID: 18953056 Clinical Trial. - Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice.
Luo F, Rustay NR, Seifert T, Roesner B, Hradil V, Hillen H, Ebert U, Severin JM, Cox BF, Llano DA, Day M, Fox GB. Luo F, et al. J Pharmacol Exp Ther. 2010 Dec;335(3):580-8. doi: 10.1124/jpet.110.172932. Epub 2010 Sep 7. J Pharmacol Exp Ther. 2010. PMID: 20823195 - Antibody therapy for Alzheimer's disease.
Morgan D. Morgan D. Expert Rev Vaccines. 2003 Feb;2(1):53-9. doi: 10.1586/14760584.2.1.53. Expert Rev Vaccines. 2003. PMID: 12901597 Review. - Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V, Steinitz M. Geylis V, et al. Autoimmun Rev. 2006 Jan;5(1):33-9. doi: 10.1016/j.autrev.2005.06.007. Epub 2005 Aug 1. Autoimmun Rev. 2006. PMID: 16338209 Review. - In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
Poduslo JF, Ramakrishnan M, Holasek SS, Ramirez-Alvarado M, Kandimalla KK, Gilles EJ, Curran GL, Wengenack TM. Poduslo JF, et al. J Neurochem. 2007 Jul;102(2):420-33. doi: 10.1111/j.1471-4159.2007.04591.x. J Neurochem. 2007. PMID: 17596213
Cited by
- Advancements in Pharmacological Treatment of Alzheimer's Disease: The Advent of Disease-Modifying Therapies (DMTs).
Wang Q, Chen S, Wang J, Shang H, Chen X. Wang Q, et al. Brain Sci. 2024 Sep 29;14(10):990. doi: 10.3390/brainsci14100990. Brain Sci. 2024. PMID: 39452004 Free PMC article. Review. - Amyloid-β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects.
Yu Y, Yu S, Battaglia G, Tian X. Yu Y, et al. Ibrain. 2024 May 23;10(3):266-289. doi: 10.1002/ibra.12155. eCollection 2024 Fall. Ibrain. 2024. PMID: 39346788 Free PMC article. Review. - Differences in the cerebral amyloid angiopathy proteome in Alzheimer's disease and mild cognitive impairment.
Leitner D, Kavanagh T, Kanshin E, Balcomb K, Pires G, Thierry M, Suazo JI, Schneider J, Ueberheide B, Drummond E, Wisniewski T. Leitner D, et al. Acta Neuropathol. 2024 Jul 22;148(1):9. doi: 10.1007/s00401-024-02767-1. Acta Neuropathol. 2024. PMID: 39039355 Free PMC article. - Cerebral Amyloid Angiopathy in Patients with Cognitive Impairment: Cerebrospinal Fluid Biomarkers.
Rothenberg KG, Bekris L, Leverenz JB, Wu J, Lee J, Statsevych V, Ruggieri P, Jones SE. Rothenberg KG, et al. Dement Geriatr Cogn Disord. 2024;53(5):248-254. doi: 10.1159/000539884. Epub 2024 Jun 18. Dement Geriatr Cogn Disord. 2024. PMID: 38889704 Free PMC article. - ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells.
Lee J, Lee H, Lee H, Shin M, Shin MG, Seo J, Lee EJ, Park SA, Park S. Lee J, et al. Nat Commun. 2023 Dec 20;14(1):8463. doi: 10.1038/s41467-023-44319-3. Nat Commun. 2023. PMID: 38123547 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources